| 浅析伊立替康联合FP方案治疗晚期食管癌疗效 |
|
|
|
代肿瘤内科治疗方案评价.北京大学医学出版社，2004,7:7273.
［3］王瑞林.晚期、复发转移性食管癌姑息性药物治疗进展. 肿瘤基础与临床, 2009,22(1):8390.
［4］ Ilson DH,Saltz L, Enzinqer P, et al. Phase II trial ofweekly irinotecan p lus cisp latin in advanced esophageal cancer. J Clin Oncol, 1999,17(10):3270.
［5］ Ajani JA, Baker J, Pisters PW, et al. Mansfi eld PF,FEIg BW, Charnsangavej C. CPT11 plus cisplatinin patients with advanced, untreated gastric or gastroesophageal junction carcinoma:results of aphase II study. Cancer,2002,94:641646.
［6］ MührWilkenshoff F, Hinkelbein W, Ohnesorge I, et al.
Apilot of irinotecan(CPT11)as singleagent therapy in patients with locally advanced ormetastatic esophageal carcinoma. Int J Colorectal Dis,2003,18(4):330334. 上一页 [1] [2] [3] [4] [5] [6] |
|
|
| |
|
上一个论文： 浅析杭锦后旗浅层地下水砷赋存形态
下一个论文： 浅谈分泌性中耳炎致儿童骨导听阈下降21例 |
|
用户登录 
新用户注册 